Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Stamford, CT
SEC filing record 1 source field available
Fiscal year end
31 December
Point72 Asset Management, L.P. has filed 1,033 SEC EDGAR filings since 08 Apr 2014

SEC filing history

Showing 351-375 of 1,000 matching filings.

Per page
25
Current page
15
SC 13G

CELLDEX THERAPEUTICS, INC.

Filing date
20 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

LYRA THERAPEUTICS, INC.

Filing date
16 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16256

13F-HR filing

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

KORRO BIO, INC.

Filing date
09 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SYNDAX PHARMACEUTICALS INC

Filing date
31 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SEMTECH CORP

Filing date
20 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIOHAVEN LTD.

Filing date
18 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

MADISON SQUARE GARDEN ENTERTAINMENT CORP.

Filing date
10 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

RAPID7, INC.

Filing date
10 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

VISTAGEN THERAPEUTICS, INC.

Filing date
05 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TPI COMPOSITES, INC

Filing date
05 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

MORPHIC HOLDING, INC.

Filing date
02 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIONOMICS LIMITED/FI

Filing date
29 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CRINETICS PHARMACEUTICALS, INC.

Filing date
18 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CYBIN INC.

Filing date
15 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16256

13F-HR filing

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TURNSTONE BIOLOGICS CORP.

Filing date
27 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

HEALTH CATALYST, INC.

Filing date
27 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CHEWY, INC.

Filing date
20 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CARIBOU BIOSCIENCES, INC.

Filing date
20 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PRAXIS PRECISION MEDICINES, INC.

Filing date
26 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

COGENT BIOSCIENCES, INC.

Filing date
01 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ELEVATION ONCOLOGY, INC.

Filing date
24 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CUTERA INC.

Filing date
16 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16256

13F-HR filing

Filing date
15 May 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .